股票/基金 实时行情 股吧

简称:普利制药 代码:300630


会计年度:2018-06-30收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
非甾体30,043,802.013,319,156.7326,724,645.2888.95
抗过敏103,403,677.1010,229,767.5393,173,909.5790.11
抗生素57,689,394.3213,041,556.0844,647,838.2477.39
其他26,940,768.528,959,068.8517,981,699.6766.75

会计年度:2017-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
医药制造业324,540,975.6255,269,233.42269,271,742.2082.97

会计年度:2017-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
非甾体20,541,702.692,836,347.6617,705,355.0386.19
合计122,508,545.5030,116,489.6992,392,055.8175.42
抗过敏56,045,331.268,745,799.5547,299,531.7184.40
抗生素19,780,781.097,765,264.2712,015,516.8260.74
其他16,340,573.016,572,106.919,768,466.1059.78
消化类9,800,157.474,196,971.305,603,186.1757.17

    2/2 转到